Neogenomics stock hits 52-week high at 16.46 USD

NeoGenomics Inc. (NEO) stock has reached a 52-week high of $16.46, driven by strong investor confidence and recent positive financial results. Despite being considered overvalued by InvestingPro analysis, the company's stock has delivered a 170% return over the past year, with analysts predicting profitability and upward earnings revisions. NeoGenomics also reported strong Q2 2026 earnings, exceeding expectations and leading to raised full-year guidance.